Skip to main content
Diana Barb on Muck Rack

Diana Barb

As seen in: Color Research & Application, Sparda-Bank web.Börsenforum
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Diana

Contact Diana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PSD Bank Rhein-Ruhr eG

|
By Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Fernando Bril
| Sparda-Bank web.Börsenforum
* As previously reported(1), the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy ((1)H-MRS) following 24 weeks of treatment in patients with MASLD and T2D * A significantly higher proportion of patients achieved a greater than 30% liver triglyceride reduction as well as MASLD resolution with lanifibranor compared to placebo * Lanifibranor treatment significantly...
Open in Who Shared View Duplicates (98) Issue with article?

PSD Bank Rhein-Ruhr eG

|
By Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Fernando Bril
| Sparda-Bank web.Börsenforum
* The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. * Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected for presentation.
Open in Who Shared View Duplicates (64) Issue with article?

Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study

|
By Diana Barb, Tamara Al-Hakim, Leslie Serchuck, Diana Gomez Manjarres
| openres.ersjournals.com
Bashar N. Alzghoul, Farah N. Amer, Diana Barb, Ayoub Innabi, Mamoun T. Mardini, Chen Bai, Bara Alzghoul, Tamara Al-Hakim, Noopur Singh, Mindy Buchanan, Leslie Serchuck, Diana Gomez Manjarres, Whitney W. Woodmansee, Lisa A. Maier, Divya C. Patel ERJ Open Research 2021 7: 00754-2020; DOI: 10.1183/23120541.00754-2020 Abstract Little is known about the prevalence, clinical characteristics and impact of hypothyroidism in patients with sarcoidosis.
Open in Who Shared Issue with article?
See all 7 articles